• Product nameAnti-PEX14 antibody
    See all PEX14 primary antibodies
  • Description
    Mouse monoclonal to PEX14
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Recombinant fragment
    Predicted to work with: Human
  • Immunogen

    Recombinant fragment: LGPQEEGEGV VDVKGQVRME VQGEEEKRED KEDEEDEEDD DVSHVDEEDC LGVQREDRRG GDGQINEQVE KLRRPEGASN ESE, corresponding to amino acids 293-375 of human PEX14 (NP_004556) with a 26 kDa tag.



Our Abpromise guarantee covers the use of ab76862 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 - 5 µg/ml. Predicted molecular weight: 41 kDa. This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.
ELISA Use at an assay dependent dilution. Detection limit ~3ng/ml when used as a capture antibody.


  • FunctionComponent of the peroxisomal translocation machinery with PEX13 and PEX17. Interacts with both the PTS1 and PTS2 receptors. Binds directly to PEX17.
  • Involvement in diseaseDefects in PEX14 are the cause of peroxisome biogenesis disorder complementation group K (PBD-CGK) [MIM:601791]. PBD-CGK is a peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).
    Defects in PEX14 are a cause of Zellweger syndrome (ZWS) [MIM:214100]. ZWS is a fatal peroxisome biogenesis disorder characterized by dysmorphic facial features, hepatomegaly, ocular abnormalities, renal cysts, hearing impairment, profound psychomotor retardation, severe hypotonia and neonatal seizures. Death occurs within the first year of life.
  • Sequence similaritiesBelongs to the peroxin-14 family.
  • Cellular localizationPeroxisome membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • dJ734G22.2 antibody
    • NAPP2 antibody
    • NF E2 associated polypeptide 2 antibody
    • Peroxin 14 antibody
    • Peroxin-14 antibody
    • Peroxisomal biogenesis factor 14 antibody
    • Peroxisomal membrane anchor protein PEX14 antibody
    • Peroxisomal membrane anchor protein Pex14p antibody
    • Peroxisomal membrane protein PEX14 antibody
    • pex14 antibody
    • PEX14_HUMAN antibody
    • Pex14p antibody
    • PTS1 receptor docking protein antibody
    • PTS1 receptor-docking protein antibody
    see all

Anti-PEX14 antibody images

  • Anti-PEX14 antibody (ab76862) at 5 µg/ml + immunogen at 0.2 µg

    Goat anti-mouse IgG (H&L)-HRP conjugate at 1/5000 dilution

    Predicted band size : 41 kDa
    Observed band size : 35 kDa (why is the actual band size different from the predicted?)
  • Detection limit for ab76862 is approximately 3ng/ml as a capture antibody.

References for Anti-PEX14 antibody (ab76862)

ab76862 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab76862.
Please use the links above to contact us or submit feedback about this product.